Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04872725
Other study ID # Covid-19 OT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2020
Est. completion date July 30, 2020

Study information

Verified date May 2021
Source Istanbul Medipol University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Objective: The purpose of this study was to investigate the effect of the Covid-19 process on time management, participation, and leisure time activity. Methods: 531 individuals aged between 18-65 were included in the study. The individuals were evaluated with the Assessment Of Time Management Skills (ATMS) in terms of time management, with the Social Isolation Questionnaire (SIQ) in terms of participation, and with the Interest Checklist (IC) in terms of leisure time activities.


Recruitment information / eligibility

Status Completed
Enrollment 531
Est. completion date July 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - aged between 18-65 - lived the Covid-19 process in Turkey Exclusion Criteria: - did not complete the scales - did not live in Turkey

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Time management & participation & the leisure time activity
evaluated in terms of leisure time activities, time management and participation

Locations

Country Name City State
Turkey Istanbul Medipol University Beykoz Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of Time Management Skills It is a 30-item assessment tool that describes how different practical situations related to time management in a person's life are resolved or one's possible views on one's own time management skills. The scale is in 4-likert format and is evaluated as "1: Never, 2: Sometimes, 3: Most of the time, 4: Always" and the scores obtained are scored between 30-120. High scores indicate that time management skills and practices perform better. Eight items are reverse scored (items 7, 9, 10, 12, 18, 23, 26 and 30) from March to June
Primary Social Isolation Questionnaire It consists of 6 items that evaluate the loneliness and perceived social isolation of the individual. A minimum score of 0 and a maximum of 24 points are obtained on the scale. 0 points means total social isolation, 24 points means high social relations. A value between 0-10 means complete social isolation, a value between 12-15 means isolation, a value between 16-18 means partial isolation, a value between 19-21 means social relation, and a value between 21-24 means a high social relationship. from March to June
Primary Interest Checklist It is suitable for all population groups. The areas of interest are divided into 9 categories in each section, where relevant activities are listed and the individual can add their own activity. For each activity, it questions participation in the activity (in the past, ongoing and / or planned in the future) and degree of interest (strong, little, nothing). from March to June
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3